Award
National Institute on Aging 1R43AG094422-01
TauTrace™: An ultrasensitive immunoassay for neurodegenerative protein biomarkers
Recipient
Not specified
Award Amount
$499,940.00
Ceiling
$499,940.00
Awarded
September 11, 2025
Identifier
1R43AG094422-01
Award for development and validation of TauTrace™ immunoassay platform to detect tau protein biomarkers for Alzheimer's Disease, funded by NIH with an award amount of approximately $499,940.
Description
The project aims to develop an ultrasensitive immunoassay platform called TauTrace™ for detecting tau protein biomarkers associated with Alzheimer's Disease. The project is funded by the NIH and is part of a Phase I study. The project duration is from September 11, 2025, to August 31, 2026.